MoneyWorks4Me

Kilitch Drugs India informs about annual secretarial compliance report

27 May 2026 Evaluate
Pursuant to Regulation 24A of SEBI (Listing Obligation and Disclosure Requirement) Regulations, 2015, Kilitch Drugs India has enclosed Annual Secretarial Compliance Report for the financial year ended 31 March, 2026 issued by practicing company secretary, Deep Shukla & Associates dated 15th April, 2026.

The above information is a part of company’s filings submitted to BSE.
Peers
Company Name CMP
Sun Pharma. Inds. 1842.00
Dr. Reddys Labs. 1161.00
Cipla 1365.00
Lupin 2096.00
Zydus Lifesciences 1119.50
View more..